The National Science Board releases report on U.S. “Skilled Technical Workforce”
The National Science Board this week released recommendations to address workforce demands raised in the 2017 National Academies report “Building America’s Skilled Technical Workforce.” The NSB recommendations include changing public perceptions of technical science and engineering careers, increasing publicly available data on education and skill requirements, capitalizing on ongoing federal investments within industries that rely on technical workers, and establishing pathways, beginning in K-12, to post-secondary education to bolster job attainment. The report highlights a demand of 3.4 million workers by 2022 and emphasizes the need for all stakeholder groups to come together to meet this workforce shortage. Read the full NSB report here.
Environmental Protection Agency to phase out the use of animal testing by 2035
Andrew Wheeler, administrator for the U.S. Environmental Protection Agency, announced in a memorandum this week that the agency, which funds research on environmental concerns that impact public health, will reduce the use of animal testing in its funded research and completely eliminate the use of mammals by 2035. The memo includes a call to other federal agencies to follow suit. Wheeler has tasked senior EPA leaders with developing a strategic plan that shifts its toxicology portfolio toward utilizing nonanimal models and ensures that the agency’s mission to protect human health and the environment continues. The agency also announced that it has awarded grants to five institutions to research and develop new methods to reduce and replace vertebrate animal models. Read more on the announcement here.
The White House seeks input on the bioeconomy
The White House Office of Science and Technology Policy is soliciting from the public suggestions on how the federal government can bolster the bioeconomy. More specifically, submissions should address gaps in infrastructure and system vulnerabilities and suggest new areas of investment that may affect healthcare, biomedicine, pharmaceuticals, manufacturing, energy production and agriculture. Responses are due by Oct. 22. Read the full notice here.